Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04042701 |
|---|---|
| Brief Title: | DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer |
| First Submitted : | July 31, 2019 |
| First Submitted that Met QC Criteria : | July 31, 2019 |
| First Posted : | August 2, 2019 |
| Last Update Submitted that Met QC Criteria : | March 20, 2024 |
| Last Update Posted : | March 22, 2024 |